NEW YORK (GenomeWeb News) – Hologic said today that its proposed $580 million acquisition of Third Wave Technologies has received from the Federal Trade Commission early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
 
Hologic announced two weeks ago that it will acquire Third Wave Technologies for $11.25 per share, a 24 percent premium to Third Wave’s average trading price during the preceding three months. 
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.